Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. - Test2 - elhamkhani - TriplyDB

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

http://www.wikidata.org/entity/Q45731563

about

New perspectives on management of idiopathic pulmonary fibrosis Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review Managing comorbidities in idiopathic pulmonary fibrosis Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.Pulmonary hypertension in patients with idiopathic pulmonary fibrosis - the predictive value of exercise capacity and gas exchange efficiency.Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension.Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease Can a Six-Minute Walk Distance Predict Right Ventricular Dysfunction in Patients with Diffuse Parenchymal Lung Disease and Pulmonary Hypertension?Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer.Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications.The Impact of Pulmonary Arterial Pressure on Exercise Capacity in Mild-to-Moderate Cystic Fibrosis: A Case Control Study Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases.Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia?Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats.Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg.Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary exercise testing the Holy Grail?

P2860

Q26765586-448E2D6F-A5E1-48D7-A83F-E3C7FC52DF8A Q26781255-76769BEA-3D4C-40FC-A1C4-34F05CECA515 Q26785617-D3371640-6B88-488E-8E9E-699042509918 Q30412726-3EAE990E-3F2C-4698-AB54-47A418236B9D Q33784753-40DC022E-87B4-41C1-8AA6-FC6E1D8C4E41 Q34343972-893ECE23-F7CD-4A6B-AEC9-4DB4B2DC0AA3 Q34804620-FDE36371-2C50-4807-8E1A-1F456DBE1DFD Q36817403-8AEE10A4-91F2-434C-8F65-312890C1B6A5 Q36996749-B2C484F3-380F-4D05-988E-3A03614E3524 Q37201770-4FA74F9D-0E94-4784-A9EB-F863371497DD Q37976117-0F327A88-AF4A-48A4-9BD0-8A12DE907CA0 Q38837394-5DE846A3-9CD8-47A9-B194-9C01991CF2CD Q42118052-91A92411-D1BC-46CD-B1E4-95DA5AC7FDD1 Q43184339-214D8027-438D-4AF5-947B-8AA9D87F8404 Q46109875-09332978-D6B3-4375-8E83-AA8C9F2F5860 Q46356750-3C18A742-E464-423A-95FC-2A04AF645E55 Q48111085-754B190A-D610-4C5F-9AFE-67AA1B1EBC00 Q50098235-A734F3B3-5A13-4F6C-B58F-393FD09A6C41 Q51723391-40C1A5F6-A030-40B6-B94C-65AB54AE74CA

P2860

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

http://www.wikidata.org/entity/Q45731563

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@en

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@nl

type

label

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@en

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@nl

prefLabel

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@en

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@nl

P1433

Q45731563-C649AC69-67E2-48AE-87C1-D5D973843DD5

P1476

Q45731563-B46B5D8D-4AD9-47F1-9336-C0164BB44A0F

P2093

Q45731563-0F099D1C-29E9-4CF2-BD30-5D2C3F9165BF

Q45731563-16DE3D3E-8C16-4D30-93CA-F7E3AF304880

Q45731563-2AAAE2A0-EA5D-435D-B125-334D3DFE5449

Q45731563-31D52F1A-426F-467A-87AB-C1DD2AE2E0C4

Q45731563-3453748A-CB12-4F81-B276-B116EF1527E4

Q45731563-6537AF59-F965-4254-B73F-FF6E68973091

Q45731563-908633D1-C097-48C9-83D5-9CFF133730D6

Q45731563-B4976116-77B2-4B52-B683-CBEE0AA9F1A8

Q45731563-BB12E4C4-F020-4053-8471-51ED0C19927B

Q45731563-FFC2F4B2-70DC-4FB6-BBF0-750A3625E784

P2860

Q45731563-006FA58F-C771-4F2E-A5A9-64896FF5D6CB

Q45731563-0560195B-49CD-4B08-8F7F-473AB1A8A97B

Q45731563-105273A7-DA69-46CE-8624-D673F42F8D03

Q45731563-1812A0F5-B025-4975-816E-F10E88B9C4F3

Q45731563-18AD9168-39AB-4CBF-8B95-D44FC18682C3

Q45731563-1EC17225-3221-4D7D-9D52-6E44A5FB591B

Q45731563-456CF870-0D1A-44E3-BCC5-C8887DFE1948

Q45731563-776E9AA6-EECF-46C8-A18F-41411262D41A

Q45731563-982E198E-3BFA-4801-875B-9764888F5528

Q45731563-9F593996-D66F-48F3-BD86-71F1075C04F6

P304

Q45731563-816F6F06-4E02-48A1-85C4-BAC8808F86FE

P31

Q45731563-248130CE-70F7-41AA-AF40-0223035BA5B7

P356

Q45731563-2D5F82E0-24AA-40FD-A222-421919E9A392

P433

Q45731563-0559C6A7-B62D-4313-8072-3DC38E07F2D1

P478

Q45731563-2C6D9BA7-6CCF-46EE-BB9A-EFBE5C121DBB

P577

Q45731563-AE1A4DDE-41DA-49FC-9A40-B05333A5FF78

P698

Q45731563-B4D45AA5-979D-4BA2-91A6-18A64AAA8527

P921

Q45731563-51DD021F-0C24-4F7B-8EFF-5BC4DED0FBE7

P356

J.1440-1843.2010.01909.X

P1433

P1476

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.

@en

P2093

Afroditi K Boutou

http://www.w3.org/2001/XMLSchema#string

Chrysanthi Nakou

http://www.w3.org/2001/XMLSchema#string

Despina Papakosta

http://www.w3.org/2001/XMLSchema#string

Georgia G Pitsiou

http://www.w3.org/2001/XMLSchema#string

Ioannis Stanopoulos

http://www.w3.org/2001/XMLSchema#string

Ioannis Trigonis

http://www.w3.org/2001/XMLSchema#string

Karlman Wasserman

http://www.w3.org/2001/XMLSchema#string

Nikolaos Chavouzis

http://www.w3.org/2001/XMLSchema#string

Paraskevi Argyropoulou

http://www.w3.org/2001/XMLSchema#string

Paschalina K Kontou

http://www.w3.org/2001/XMLSchema#string

P2860

A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension.

Diagnosis and differential assessment of pulmonary arterial hypertension.

ATS/ACCP Statement on cardiopulmonary exercise testing.

Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.

Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.

Pulmonary hypertension in idiopathic pulmonary fibrosis.

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases.

Exercise-induced pulmonary arterial hypertension.

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.

P304

451-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1843.2010.01909.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21122030

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis